| 000 | 01582 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516134749.0 | ||
| 264 | 0 | _c20141001 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1476-5578 | ||
| 024 | 7 |
_a10.1038/mp.2013.18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndreasson, U | |
| 245 | 0 | 0 |
_aCSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4. _h[electronic resource] |
| 260 |
_bMolecular psychiatry _cFeb 2014 |
||
| 300 |
_a148-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aApolipoprotein E4 _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPeptide Fragments _xcerebrospinal fluid |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_atau Proteins _xcerebrospinal fluid |
| 700 | 1 | _aLautner, R | |
| 700 | 1 | _aSchott, J M | |
| 700 | 1 | _aMattsson, N | |
| 700 | 1 | _aHansson, O | |
| 700 | 1 | _aHerukka, S-K | |
| 700 | 1 | _aHelisalmi, S | |
| 700 | 1 | _aEwers, M | |
| 700 | 1 | _aHampel, H | |
| 700 | 1 | _aWallin, A | |
| 700 | 1 | _aMinthon, L | |
| 700 | 1 | _aHardy, J | |
| 700 | 1 | _aBlennow, K | |
| 700 | 1 | _aZetterberg, H | |
| 773 | 0 |
_tMolecular psychiatry _gvol. 19 _gno. 2 _gp. 148-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/mp.2013.18 _zAvailable from publisher's website |
| 999 |
_c22514337 _d22514337 |
||